# SLN Detection With Tc-MSA-ICG in Lung Cancer Patients

> **NCT05039905** · EARLY_PHASE1 · UNKNOWN · sponsor: **Korea University Guro Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** 99mTc-MSA-ICG

## Key facts

- **NCT ID:** NCT05039905
- **Lead sponsor:** Korea University Guro Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-15
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05039905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05039905, "SLN Detection With Tc-MSA-ICG in Lung Cancer Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05039905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*